Lexaria Releases Annual Letter from the CEO: A Charming and Engaging Recap of Consumer and Retail Products
Charmingly Eccentric: A Letter from Lexaria Bioscience Corp. CEO CEO Letter to Stakeholders KELOWNA, BC / ACCESS Newswire / January 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), a global innovator in drug delivery platforms is pleased to provide this annual letter from its Chief Executive Officer (“CEO”) Richard Christopher as a strategic update to all…